Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Measuring brain atrophy. What can be done and where are we heading?

Measuring brain atrophy. What can be done and where are we heading?

Falling chronically ill – How do I cope and move forward?

Falling chronically ill – How do I cope and move forward?

Cognitive decline – The invisible burden of MS?

Cognitive decline – The invisible burden of MS?

Lp(a) as ASCVD risk factor

Lp(a) as ASCVD risk factor

Cognitive training – A curse or a blessing?

Cognitive training – A curse or a blessing?

PCSK9 Inhibitors in Real World Practice

PCSK9 Inhibitors in Real World Practice

How old is your brain?

How old is your brain?

The role and importance of Patients Associations and Scientific societies ; UAE experience

The role and importance of Patients Associations and Scientific societies ; UAE experience

Exercise as ”medicine” in the treatment of MS

Exercise as ”medicine” in the treatment of MS

Understanding Ttp

Understanding Ttp

TTP is a life-threatening thrombotic microangiopathy (TMA) that requires quick diagnosis and urgent treatment. 1,2

A promising biomarker in MS: Neurofilament light chain

A promising biomarker in MS: Neurofilament light chain

PCSK9i and Prevention of CVD

PCSK9i and Prevention of CVD

The synopsis of a Cochrane Systematic review on PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.